(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -1.08% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.22%.
Pfizer's revenue in 2025 is $63,833,000,000.On average, 23 Wall Street analysts forecast PFE's revenue for 2025 to be $361,072,255,603,500, with the lowest PFE revenue forecast at $342,156,429,090,000, and the highest PFE revenue forecast at $382,205,446,812,000. On average, 23 Wall Street analysts forecast PFE's revenue for 2026 to be $358,610,412,237,000, with the lowest PFE revenue forecast at $325,429,539,519,000, and the highest PFE revenue forecast at $386,281,986,520,500.
In 2027, PFE is forecast to generate $350,144,627,542,500 in revenue, with the lowest revenue forecast at $313,671,821,085,000 and the highest revenue forecast at $399,381,494,872,500.